Ranger™ and Ranger™ SL (OTW) DCB) in China

Inclusion Criteria: * Subjects must be age 18 or older * Subject is willing and able to provide informed consent * Subject is available and willing to attend all required follow-up visits * Subject has a clinically significant symptomatic leg ischemia * Subject has a Rutherford clinical category of 2 - 4 * If the index lesion is restenotic, the prior PTA must have been \> 90 days prior to treatment in the current study * Only one lesion per limb can be treated under this protocol, which means that one index lesion, on one index limb will be "in treatment". However, both limbs may be treated during either the index procedure and/or subsequent procedures * Successful intraluminal wire crossing of the target lesion Angiographic Inclusion Criteria: * Al1.The index lesion is a clinically and hemodynamically de novo stenotic or restenotic lesion located in the native nonstented superficial femoral artery or proximal popliteal artery between the Hunter's Canal and the popliteal fossa (i.e. within the P1 segment), with the following characteristics by visual assessment: * Degree of stenosis ≥ 70% * Target vessel diameter ≥ 2.0 mm and ≤ 8.0 mm * Lesion length ≥ 20 mm and ≤ 200 mm, to be covered by one or two balloon(s) (with minimal overlap) * For diffuse lesion or multiple lesions in the same target vessel, the total lesion length, including the distance between lesions, must be ≤ 200 mm * AI2. The subject has at least one patent infrapopliteal artery (\< 50% stenosis) to…